论文部分内容阅读
目的观察奥扎格雷钠注射液治疗急性脑梗死的临床疗效。方法选择我科收治的急性脑梗死患者114例,随机分为治疗组60例和对照组54例。治疗组给予奥扎格雷钠注射液治疗,对照组给予银杏达莫注射液治疗,连用15d,观察两组患者治疗前后神经功能缺损评分和临床疗效。结果两组患者治疗后7d神经功能缺损评分间差异无统计学意义(P>0.05),治疗15d神经功能缺损评分间差异有统计学意义(P<0.05)。两组显效率及有效率差异有统计学意义(P﹤0.05)。结论奥扎格雷钠注射液治疗急性脑梗死,有助于神经功能的改善,提高疗效,早期应用可促进神经功能恢复,改善预后。
Objective To observe the clinical efficacy of sodium ozagrel in the treatment of acute cerebral infarction. Methods 114 patients with acute cerebral infarction admitted to our department were randomly divided into treatment group (60 cases) and control group (54 cases). The treatment group was given sodium ozagrel injection, while the control group was treated with ginkgo dipyridamole injection for 15 days. The scores of neurological deficits and clinical efficacy of the two groups before and after treatment were observed. Results There was no significant difference in neurological deficit score between the two groups on the 7th day after treatment (P> 0.05). There was significant difference in neurological deficit score between the two groups (P <0.05) 15d after treatment. Significant difference between the two groups was significant and effective rate (P <0.05). Conclusion Ozagrel sodium injection in the treatment of acute cerebral infarction can help improve the neurological function and improve the curative effect. Early application can promote the recovery of neurological function and improve the prognosis.